Apply on Employer Site

Glaukos Corporation · 2 months ago

Interventional Business Manager - 10 Openings!

Indianapolis, IN, United States

Full-time

Onsite

Mid Level

$125K/yr - $125K/yr

Glaukos Corporation is a leader in innovative chronic eye disease technologies, and they are seeking an Interventional Business Manager. In this role, you will drive the adoption of advanced ophthalmic technologies within clinical practices, collaborating with surgeons and practice teams to expand patient access and ensure successful implementation of innovative solutions.

Health CareMedicalWellness

Growth Opportunities

Responsibilities

Drive the adoption and integration of advanced ophthalmic technologies within clinical practices

Collaborate with surgeons and practice teams to expand patient access

Provide clinical and business support

Ensure successful implementation of innovative solutions

Blend strategic sales execution with education and customer partnership to improve patient outcomes and grow market presence

Qualification

Sales account managementMedical devices experienceOphthalmic technologies knowledgeClinical practices understandingClinical supportBusiness supportPatient outcomes improvementMarket presence growthCommunicationCollaborationStrategic thinking

Required

Experience in sales account management within the medical devices industry

Strong understanding of ophthalmic technologies and clinical practices

Proven ability to drive adoption and integration of new technologies

Excellent communication and collaboration skills

Ability to work strategically with surgeons and practice teams

Experience in providing clinical and business support

Demonstrated success in improving patient outcomes and growing market presence

Benefits

Total Targeted Compensation Package: $260+

Company

Glaukos Corporation

At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.

Founded in 1998

San Clemente, California, USA

1001-5000 employees

http://www.glaukos.com

Funding

Current Stage

Public Company

Total Funding

$121M

Key Investors

Meritech Capital PartnersOrbiMed

2015-06-25IPO

2013-02-07Series F· $30M

2012-10-03Debt Financing· $6M

Leadership Team

Alex Thurman

Senior Vice President and Chief Financial Officer

Joseph Gilliam

President & Chief Operating Officer

Recent News

Orange County Business Journal

Midday Stock Roundup: Shimmick Drops on Low Volume

2026-01-24

Orange County Business Journal

Do Not Use

2026-01-22

BioSpace

Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance

2026-01-16

Company data provided by crunchbase